[Infographics] Expanding roles of semaglutide in CKM syndrome

23 Oct 2025
[Infographics] Expanding roles of semaglutide in CKM syndrome
Semaglutide is a key organ-protective medication for managing cardio-kidney-metabolic (CKM) syndrome. Discover more about positive trial results across seven key components of CKM syndrome, and upcoming data on semaglutide. 
The above editorial is for medical education purpose supported by Novo Nordisk.

Related MIMS Drugs

Resources

[Infographics] Expanding roles of in semaglutide CKM syndrome

[Infographics] Expanding roles of in semaglutide CKM syndrome

[Infographics] Expanding roles of in semaglutide CKM syndrome

[Infographics] Expanding roles of in semaglutide CKM syndrome